Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Obesity (Silver Spring). 2009 Oct;17(10):1976-8. doi: 10.1038/oby.2009.219. Epub 2009 Jul 23.

Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes.

Author information

  • 1Human Physiology, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Abstract

The size of adipocytes influences their function suggesting a differential responsiveness to intervention. We hypothesized that weight loss in patients with type 2 diabetes mellitus (T2DM) predominantly decreases the size of large and very-large adipocyte subfractions in parallel with beneficial changes in serum adipokines and improved insulin sensitivity. A total of 44 volunteers from the Look Action for Health in Diabetes trial, who lost weight after 1-year of intense lifestyle intervention, were included. Insulin sensitivity (hyperinsulinemic-euglycemic clamp), size of subcutaneous abdominal adipocytes (osmium fixation), and selected serum adipokines were measured. A 13% weight loss was accompanied by 46% improvement in insulin sensitivity (increased glucose disposal rate from 5.9+/-2.2 to 8.6+/-2.7 mg/min/kg fat-free mass, P<0.05) in parallel with a 36% increase in plasma adiponectin concentration (6.1+/-3.1 to 8.3+/-3.9 microg/ml, P<0.05], but no changes in the proinflammatory cytokines interleukin-6 and tumor necrosis factor-alpha. Change in adiponectin correlated with changes in glucose disposal rate (r=0.34, P<0.05). Mean adipocyte size decreased (0.84+/-0.25 to 0.64+/-0.23 microl, P<0.05), mainly due to changes in the large adipocyte subfraction (size 0.75-0.44 microl, relative number 19-26%; P<0.05). Our data suggest that change in the large adipocyte subfraction may contribute to the improvement in insulin sensitivity via an increase in serum adiponectin. Such a relationship, which does not imply cause and effect, could not be obtained by measuring only mean adipocyte size. These data provide support for the measures of adipocyte size distribution in concert with in vitro adipokine secretion and lipolysis in future studies.

PMID:
19629054
[PubMed - indexed for MEDLINE]
PMCID:
PMC3985333
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk